Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Trimegah Bangun Persada Tbk. (NCKL)

UBC Medical Indonesia Tbk.Trading
Trimegah Bangun Persada Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Trimegah Bangun Persada Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb), sedangkan Trimegah Bangun Persada Tbk. diperdagangkan di Rp910 (kapitalisasi pasar 59 T, volume 24 jam 32,17 jt). Perbedaan utamanya: Trimegah Bangun Persada Tbk. jauh lebih besar — sekitar 92,8× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Trimegah Bangun Persada Tbk. lebih aktif diperdagangkan (32,17 jt vs 843 rb). Mana yang lebih baik tergantung tujuan investasimu.

LABSNCKL
Kapitalisasi Pasar
635,95 M59 T
Volume
843 rb32,17 jt
Lot
8,43 rb321,67 rb
Perputaran
137,6 jt29,46 M
Harga Rata-rata
163,22915,97
Nilai Transaksi
137,6 jt29,46 M
Harga Ekuilibrium Indikatif
165910
Volume Ekuilibrium Indikatif
2466,73 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
NCKL
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Trimegah Bangun Persada Tbk.

PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.

Selengkapnya di halaman NCKL